BUSINESS4 years ago
Generex Biotechnology Corporation’s (OTCMKTS:GNBT) Subsidiary Nugenerex Immuno-Oncology To Develop New Swine Flu Virus Vaccine
Generex Biotechnology Corporation’s (OTCMKTS:GNBT) wholly-owned subsidiary NuGenerex Immuno-Oncology launched a vaccine development initiative to address the emerging new pandemic threat from the recently identified Swine flu...